Deutsche Bank
BCAX

Deutsche Bank’s Bicara Therapeutics BCAX Stock Holding History

Deutsche Bank’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Buy
144,010
+12,354
+9% +$276K ﹤0.01% 1452
2026
Q1 		$2.62M Buy
131,656
+3,030
+2% +$52.2K ﹤0.01% 1637
2025
Q4 		$2.16M Buy
128,626
+1,171
+0.9% +$20K ﹤0.01% 1752
2025
Q3 		$2.01M Buy
127,455
+3,370
+3% +$37.7K ﹤0.01% 1771
2025
Q2 		$1.15M Buy
124,085
+12,702
+11% +$151K ﹤0.01% 2008
2025
Q1 		$1.45M Sell
111,383
-1,093
-1% -$14.5K ﹤0.01% 1956
2024
Q4 		$1.96M Buy
+112,476
New +$2.34M ﹤0.01% 1866

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's BCAX Position: Q2 2026 in Review

Deutsche Bank increased its Bicara Therapeutics (BCAX) stake by 9.4% in Q2 2026, buying an estimated $276K and bringing the position to 144,010 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1452.

Deutsche Bank first reported a position in BCAX in Q4 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Deutsche Bank held 144,010 shares of Bicara Therapeutics worth $4.28M as of Q2 2026.
  • Deutsche Bank bought 12,354 Bicara Therapeutics shares in Q2 2026, an estimated $276K.
  • Bicara Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1452 holding.
  • Deutsche Bank first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.